Pay in 4 interest-free payments of $6.93 Learn more
Ships within 48 hours · Estimated delivery Aug 6 - Aug 11
The objective of this post hoc analysis was to examine the incidence of 3-point MACE, including nonfatal myocardial infarction (MI), nonfatal ischemic stroke, and CV death, across different categories of weight loss achieved after 13 months of semaglutide treatment in the SUSTAIN-6 trial, as well as assess the association between weight loss categories and the incidence of MACE outcomes during the subsequent follow-up period (weeks 56104)
Cabral-PachecoGAGarza-VelozICastruita-De la RosaCRamirez-AcunaJMPerez-RomeroBAGuerrero-RodriguezJFet al
doi:10.1016/S2213-8587(19)30344-3
Similar content being viewed by others Background Obesity is an important issue of human health in the world today
Pharmacological inhibitors targeting caspase-1 activity have been investigated for their potential to dampen the inflammatory response and reduce tissue damage in APAP-induced liver injury
US$ 26.26
US$ 27.00
US$ 20.45
US$ 25.53
US$ 23.58
